Published in Biotech Business Week, November 27th, 2006
Other ASR applications include CYP 450 2D6, 2C19, NAT2, UGT1A1, MDR1, 3A4/3A5 tests. Says Fareed Kureshy, CEO of AutoGenomics, "This perhaps is the most comprehensive panel of ASRs made available by any company and poises AutoGenomics to be the leader in the now emerging era of personalized medicine."
Milton Drachenburg, MD, medical director, Hematology at Long Beach Memorial Medical Center, one of AutoGenomics' expanding base of customers, said, "We currently...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.